A new drug treatment has been discovered by the team at St Vincent’s Hospital to help cure Acute Myeloid Leukaemia (AML). Acute Myeloid Leukaemia unfortunately has the highest mortality rate of any blood cancer and affects 1,000 Australians every year. 

Early research has discovered that their invention, which focuses on a small gene known as the “micro RNA-10a” inhibitor, can kill leukaemic cells when working cooperatively with another drug. They have also discovered that measuring this gene level in leukaemic cells may enable doctors to predict which patients will respond to this treatment. 

To further this research, Arrow has funded the employment of a research scientist for the next six months. Their job will be to move the research to the next critical phase by testing the drugs ‘in vivo’ in the laboratory. This will be the last step in bringing this treatment for AML to clinical trial. 

________________________

We would love your help to fund more medical research projects like these. Take a look at our fundraising page for ideas on how you can join the push to improve outcomes for bone marrow transplant patients.